Business Context and Reporting Period
Pacific Biosciences of California, Inc. filed this Form 8-K to report the results of its Annual Meeting of Stockholders held on June 23, 2011. The filing details the outcomes of three specific proposals submitted to shareholders for a vote.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics.
Material Changes
There are no financial material changes reported in this document. The material events are the successful election of directors and the shareholder approval of executive compensation policies.
Outlook, Management Commentary, and Voting Results
- Proposal 1: Election of Class I Directors
- Hugh C. Martin: Elected (34,811,311 For; 99,236 Withheld)
- Brook Byers: Elected (34,809,104 For; 101,443 Withheld)
- Susan Siegel: Elected (34,891,050 For; 19,497 Withheld)
- Proposal 2: Advisory Vote on Executive Compensation
- Result: Approved by stockholders.
- Votes: 34,779,394 For; 112,209 Against; 18,944 Abstain.
- Proposal 3: Frequency of Advisory Vote on Executive Compensation
- Result: Stockholders indicated a preference for a vote every three years.
- Votes: 24,205,257 for Three Years; 8,875,665 for One Year; 1,805,909 for Two Years; 23,716 Abstain.
- Action: The Board of Directors determined to hold the advisory vote every three years in accordance with shareholder preference.
Investor Verification Checklist
- Verify the official composition of the Board of Directors following the election of the Class I directors.
- Confirm the implementation of the three-year cycle for future executive compensation advisory votes.
- Review the full Proxy Statement referenced in the filing for detailed executive compensation disclosures.